Barrington lowered the firm’s price target on U.S. Physical Therapy to $111 from $124 and keeps an Outperform rating on the shares after the company reported “solid” Q3 results. The firm’s reduced price target is “mostly due to the tough stock market environment” as it now applies a 18.5 times multiple to its FY24 adjusted EBITDA estimate, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on USPH:
- U.S. Physical Therapy reports Q3 adjusted EPS 62c, consensus 61c
- USPH Earnings this Week: How Will it Perform?
- U.S. Physical Therapy acquires an injury prevention, ergonomics business for $4M
- U.S. Physical Therapy acquires two physical therapy practices for $13.9M
- U.S. Physical Therapy initiated with an Overweight at JPMorgan
